Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Vitamin D3 may protect rat hair follicles from radiation damage.

Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Thiosulfate may help hair grow faster in mice and works well with a common hair growth treatment.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

The treatment combination is effective and generally safe for lung cancer.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Stem cell-derived conditioned medium is effective in improving hair density and thickness for alopecia treatment.